BRVE Conversion Disclosure
Jiangsu Hengrui Pharmaceuticals Co., Ltd. · SEC Form 4 · Filed Aug 10, 2026
Conversion
Reported value range
Not reported
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% owner
BRVE
Braveheart Bio, Inc.
BRVE
Transaction date
Aug 7, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 3 days later
BRVE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,420,091 shares
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001104659-26-093140
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Braveheart Bio, Inc. BRVE Current | Conversion | Aug 7, 2026 | Not reported |
| Braveheart Bio, Inc. BRVE | Conversion | Aug 7, 2026 | $0 |